These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 30160214)

  • 41. Comparative QSAR studies on peptide deformylase inhibitors.
    Lee JY; Doddareddy MR; Cho YS; Choo H; Koh HY; Kang JH; No KT; Pae AN
    J Mol Model; 2007 May; 13(5):543-58. PubMed ID: 17333308
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models.
    Bhongade BA; Gadad AK
    J Med Chem; 2006 Jan; 49(2):475-89. PubMed ID: 16420035
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 3D-QSAR Studies on Barbituric Acid Derivatives as Urease Inhibitors and the Effect of Charges on the Quality of a Model.
    Ul-Haq Z; Ashraf S; Al-Majid AM; Barakat A
    Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27144563
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 3D QSAR studies of 1,3,4-benzotriazepine derivatives as CCK2 receptor antagonists.
    Kaur K; Talele TT
    J Mol Graph Model; 2008 Nov; 27(4):409-20. PubMed ID: 18774323
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 2D and 3D-QSAR analysis of pyrazole-thiazolinone derivatives as EGFR kinase inhibitors by CoMFA and CoMSIA.
    Pourbasheer E; Aalizadeh R; Shiri HM; Banaei A; Ganjali MR
    Curr Comput Aided Drug Des; 2015; 11(4):292-303. PubMed ID: 26548551
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular Modeling Study on Diazine Indole Acetic Acid Derivatives for CRTH2 Inhibitory Activity.
    Babu S; Rupa M; Nagarajan SK; Sohn H; Madhavan T
    Comb Chem High Throughput Screen; 2016; 19(6):444-60. PubMed ID: 27137916
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Application of 3D-QSAR, Pharmacophore, and Molecular Docking in the Molecular Design of Diarylpyrimidine Derivatives as HIV-1 Nonnucleoside Reverse Transcriptase Inhibitors.
    Liu G; Wang W; Wan Y; Ju X; Gu S
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29751616
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 3D-QSAR and molecular docking studies on pyrazolopyrimidine derivatives as glycogen synthase kinase-3beta inhibitors.
    Dessalew N; Patel DS; Bharatam PV
    J Mol Graph Model; 2007 Mar; 25(6):885-95. PubMed ID: 17018257
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CoMFA and CoMSIA studies on aryl carboxylic acid amide derivatives as dihydroorotate dehydrogenase (DHODH) inhibitors.
    Vyas VK; Ghate M
    Curr Comput Aided Drug Des; 2012 Dec; 8(4):271-82. PubMed ID: 22242798
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CoMFA and CoMSIA 3D QSAR analysis on N1-arylsulfonylindole compounds as 5-HT6 antagonists.
    Doddareddy MR; Cho YS; Koh HY; Pae AN
    Bioorg Med Chem; 2004 Aug; 12(15):3977-85. PubMed ID: 15246074
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A combined 3D-QSAR and molecular docking strategy to understand the binding mechanism of (V600E)B-RAF inhibitors.
    Ul-Haq Z; Mahmood U; Reza S
    Mol Divers; 2012 Nov; 16(4):771-85. PubMed ID: 23054531
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 3D-QSAR, molecular dynamics simulations, and molecular docking studies on pyridoaminotropanes and tetrahydroquinazoline as mTOR inhibitors.
    Chaube U; Bhatt H
    Mol Divers; 2017 Aug; 21(3):741-759. PubMed ID: 28577112
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modeling study of phenylsulfonylfuroxan derivatives as P-gp inhibitors: a combined approach of CoMFA, CoMSIA and HQSAR.
    Gadhe CG; Balupuri A; Balasubramanian PK; Cho SJ
    Anticancer Agents Med Chem; 2014; 14(7):1019-30. PubMed ID: 24066798
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 3D-QSAR (CoMFA, CoMSIA), molecular docking and molecular dynamics simulations study of 6-aryl-5-cyano-pyrimidine derivatives to explore the structure requirements of LSD1 inhibitors.
    Ding L; Wang ZZ; Sun XD; Yang J; Ma CY; Li W; Liu HM
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3521-3528. PubMed ID: 28610981
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Docking-based 3D-QSAR study of pyridyl aminothiazole derivatives as checkpoint kinase 1 inhibitors.
    Balupuri A; Balasubramanian PK; Gadhe CG; Cho SJ
    SAR QSAR Environ Res; 2014; 25(8):651-71. PubMed ID: 24911214
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CoMSIA study on substituted aryl alkanoic acid analogs as GPR40 agonists.
    Bhatt A; Patel PD; Patel MR; Singh S; Lau-Cam CA; Talele TT
    Chem Biol Drug Des; 2011 May; 77(5):361-72. PubMed ID: 21352503
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular docking and 3D-quantitative structure activity relationship analyses of peptidyl vinyl sulfones: Plasmodium Falciparum cysteine proteases inhibitors.
    Teixeira C; Gomes JR; Couesnon T; Gomes P
    J Comput Aided Mol Des; 2011 Aug; 25(8):763-75. PubMed ID: 21786172
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modification of polychlorinated phenols and evaluation of their toxicity, biodegradation and bioconcentration using three-dimensional quantitative structure-activity relationship models.
    Tong L; Guo L; Lv X; Li Y
    J Mol Graph Model; 2017 Jan; 71():1-12. PubMed ID: 27825025
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) of thiazolone derivatives as hepatitis C virus NS5B polymerase allosteric inhibitors.
    Lei B; Du J; Li S; Liu H; Ren Y; Yao X
    J Comput Aided Mol Des; 2008 Oct; 22(10):711-25. PubMed ID: 18716715
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular modelling of quinoline derivatives as telomerase inhibitors through 3D-QSAR, molecular dynamics simulation, and molecular docking techniques.
    Vishwakarma K; Bhatt H
    J Mol Model; 2021 Jan; 27(2):30. PubMed ID: 33415518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.